Apoptotic signal of Fas is not mediated by ceramide.

Ceramide has been suggested as the secondary messenger mediating the apoptotic signal for Fas engagement. By using different inhibitors, we demonstrated here that ceramide is unlikely a mediator of Fas-initiated apoptosis. First, cAMP prevented cell death induced by ceramide but not by Fas. Second, ceramide-triggered, but not Fas-triggered, apoptosis was antagonized by the free radical scavenger C60. Third, the metal chelator pyrrolidinedithiocarbamate suppressed ceramide-initiated DNA fragmentation but had no effect on the Fas-induced cell death. Fourth, the SAPK/ERK kinase dominant negative mutant, which attenuated ceramide-induced cell death, did not prevent Fas-induced apoptosis. Finally, activation of NF-kappaB inhibited ceramide-induced but not Fas-initiated apoptosis. The fact that many antagonists of ceramide-induced apoptosis could not suppress Fas-mediated cell death clearly indicates that ceramide is not the mediator for Fas-initiated apoptotic signal.

[1]  Shen,et al.  Carboxyfullerenes as neuroprotective agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Aebersold,et al.  Fas-induced apoptosis of T cells occurs independently of ceramide generation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Howard Y. Chang,et al.  Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis , 1997, Cell.

[4]  Matthias Mann,et al.  FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) , 1997, The EMBO journal.

[5]  D. Sillence,et al.  Evidence against an early signalling role for ceramide in Fas-mediated apoptosis. , 1997, The Biochemical journal.

[6]  S. Chouaib,et al.  Alteration of the Sphingomyelin/Ceramide Pathway Is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-α-mediated Cytotoxicity* , 1997, The Journal of Biological Chemistry.

[7]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[8]  J. Ashwell,et al.  Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis , 1997, Molecular and cellular biology.

[9]  Hsiu-Hsiang Lee,et al.  Overexpression of mitogen‐activated protein kinase kinase kinase reversed cAMP inhibiton of NF‐χB in T cells , 1997 .

[10]  S. Ng,et al.  CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes. , 1997, Journal of immunology.

[11]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[12]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[13]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[14]  Seamus J. Martin,et al.  Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.

[15]  B. Aggarwal,et al.  Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation. , 1996, Journal of immunology.

[16]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[17]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[18]  Y. Hannun,et al.  prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. , 1996, The Biochemical journal.

[19]  J. Jaffrezou,et al.  Daunorubicin‐induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. , 1996, The EMBO journal.

[20]  I. Macara,et al.  JNK, but not MAPK, activation is associated with Fas‐mediated apoptosis in human T cells , 1996, European journal of immunology.

[21]  S. Nagata,et al.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.

[22]  S. Spiegel,et al.  Signal transduction through lipid second messengers. , 1996, Current opinion in cell biology.

[23]  L. Zon,et al.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis , 1996, Nature.

[24]  S. C. Wright,et al.  Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24) , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  H. Petty,et al.  Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization. , 1996, Journal of immunology.

[26]  R. Testi,et al.  Multiple pathways originate at the Fas/APO‐1 (CD95) receptor: sequential involvement of phosphatidylcholine‐specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. , 1995, The EMBO journal.

[27]  A. Bielawska,et al.  Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Scotto,et al.  Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.

[29]  Y. Hsueh,et al.  c-Jun N-terminal Kinase but Not Mitogen-activated Protein Kinase Is Sensitive to cAMP Inhibition in T Lymphocytes (*) , 1995, The Journal of Biological Chemistry.

[30]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[31]  P. Golstein,et al.  The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity , 1995, The Journal of experimental medicine.

[32]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[33]  D. Green,et al.  FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. , 1995, Immunity.

[34]  L. Zon,et al.  Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun , 1994, Nature.

[35]  G. Cran,et al.  Fas Antigen and Sphingomyelin‐Ceramide Turnover‐Mediated Signaling: Role in Life and Death of T Lymphocytes 1 , 1994, Immunological reviews.

[36]  K. Schulze-Osthoff,et al.  Divergent signalling via APO‐1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. , 1994, The EMBO journal.

[37]  R. Testi,et al.  Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.

[38]  K. Schulze-Osthoff,et al.  Cell nucleus and DNA fragmentation are not required for apoptosis , 1994, The Journal of cell biology.

[39]  A. Haimovitz-Friedman,et al.  Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis , 1994, The Journal of experimental medicine.

[40]  R. Kolesnick,et al.  The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling , 1994, Cell.

[41]  M. Lai,et al.  cAMP analogs prevent activation-induced apoptosis of T cell hybridomas. , 1993, Journal of immunology.

[42]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[43]  Y. Hannun,et al.  Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. , 1993, The Journal of biological chemistry.

[44]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[45]  W. Greene,et al.  The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.